OOIR: Observatory of International Research

Papers

(The TQCC of European Heart Journal Supplements is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
C86 ASSOCIATION OF PLASMA TMAO VALUES WITH ANOTHER ISCHEMIC EVENT DURING LONG–TERM FOLLOW–UP IN PATIENTS WITH MYOCARDIAL INFARCTION	79
C48 TEN–YEARS, SINGLE–CENTER EXPERIENCE WITH MELODY TPV IMPLANTATION: EARLY OUTCOMES AND MID–TERM FOLLOW–UP	61
P330 MANAGEMENT OF HYPERKALEMIA IN A PATIENT WITH HFREF	60
P53 DOUBLE OUTLET RIGHT VENTRICLE IN PATIENT WITH XP11.23 DUPLICATION AND SYNDROMIC PHENOTYPE: BROADENING OF THE CLINICAL SPECTRUM	51
P439 INTERPRETING CARDIOVASCULAR TRIALS WITH NEUTRAL OR NEGATIVE RESULTS TRIALS: A MULTISTEP APPROACH	41
P4 TRANSTHYRETIN–INDUCED CARDIAC AMYLOIDOSIS: A RARE MUTATION IN AN ITALIAN FAMILIAL CASE	36
P293 MULTI–DIMENSIONAL EVALUATION IN PATIENTS WITH AORTIC STENOSIS CANDIDATE FOR CARDIAC SURGERY	33
P42 ACUTE STENT THROMBOSIS IN CATH LAB DURING OPTIMIZED PCI: HOW TO RECOGNIZE IT AND POSSIBLE TREATMENT	32
P152 CORONARY CT ANGIOGRAPHY A NEW PROMISING TOOL IN HEART TRANSPLANTED PATIENTS: FROM CLINICAL AND ECONOMICAL BENEFITS TO CORONARY INFLAMMATION DETECTION	28
P62 SEASON VARIABILITY IN ATHEROSCLEROSIS COMPOSITION: INSIGHTS FROM 1848 NON–CULPRIT CORONARY PLAQUES	27
BETWEEN SCYLLA AND CHARYBDIS: MULTIPLE LEFT ATRIAL THROMBI DESPITE ORAL ANTICOAGULATION AND ANTIPLATELET THERAPY IN A PATIENT CANDIDATE FOR LEFT ATRIAL APPENDAGE OCCLUSION	27
P175 PARADOXICAL RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY: A CASE REPORT	26
SEVERE MITRAL REGURGITATION TREATED WITH TRANSCATHETER AORTIC VALVE IMPLANTATION IN MITRAL RING (TMVIR): A CASE REPORT	24
THE CHALLENGING SCENARIO OF DYSPNEA IN THE ELDERLY: DUE MORE TO CONGESTION OR INFLAMMATION?	22
SAFETY AND EFFICACY OF A SINGLE PROCEDURE OF EXTRACTION AND REIMPLANTATION OF INFECTED CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE (CIED) IN COMPARISON WITH DEFERRAL TIMING: AN OBSERVATIONAL RETROSPE	21
MITRACLIP TREATMENT FOR CARDIOGENIC SHOCK DUE TO ACUTE MITRAL REGURGITATION IN A PATIENT WITH POSTINFARCTION PAPILLARY MUSCLE RUPTURE	21
OUT–OF–HOSPITAL MANAGEMENT INDICATORS IN THE APPLICATION OF THE UNIFIED PDTA "STEMI NETWORK" FOR THE AST OF ASCOLI PICENO AND FERMO: FROM DIAGNOSIS TO PCI WIRE–CROSSING. LONGITUDINAL OBSERVATIONAL CLI	20
SYNCOPE OF UNCERTAIN NATURE	19
CONTRAST STRESS ECHOCARDIOGRAPHY FINDINGS IN MYOCARDIAL BRIDGING COMPARED TO NORMAL CORONARY COURSE, WITH AND WITHOUT CORONARY ARTERY DISEASE	19
DENGUE MYOCARDITIS IN A DECEASED PATIENT WITH POSTMORTEM POSITIVE DENGUE SEROLOGY	19
P135 A CASE OF RIGHT CORONARY ARTERY ANEURYSM COMPLICATED BY ENDOVASCULAR THROMBOSIS	18
P50 ODD CONNECTIONS	18
Moodle as online platform for cardiac nurses’ competency: nursing staff experiences	18
P272 ROLE OF 3D TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN DIANOSIS OF DYSFUNCTION OF MECHANICAL PROSTHESES	18
Early detection of cardiac dysfunction in patients with breast cancer receiving antitumor therapy	17

Cardiovascular risk stratification in cancer survivors: time for a better approach?	17
ACUTE PULMONARY EMBOLISM: NEW HORIZONS IN CAT LAB	17
Snapshot of cardio-oncology practice in Italy	17
AN ISOLATED ACUTE RIGHT VENTRICULAR INFARCTION	17
Immune checkpoint inhibitor-associated myocarditis: diagnostic challenges	16
Looking beyond LVEF: cardiac and skeletal muscle function in long-term breast cancer survivors with normal versus reduced peak oxygen uptake	16
Chemotherapy induced- right ventricular dysfunction in non-Hodgkin lymphoma: a 3D echocardiographic study	16
Anthracycline exposure alters the response to future cardiac stress response driven by FOXK1	16
UTILITY OF INTRA–PROCEDURAL HIGH–DENSITY MAPPING TO IDENTIFY SUBOPTIMAL PULMONARY VEIN ISOLATION WITH PULSED–FILED ABLATION: A SINGLE–CENTER EXPERIENCE	15
RATE–RELATED LEFT BUNDLE BRANCH BLOCK IN A HIGHLY ACTIVE INDIVIDUAL: A COMPREHENSIVE WORKUP PROVIDES AN UNEXPECTED DIAGNOSIS	15
NURSE–LED AMBULATORY CARE PATHWAY IN HEART FAILURE: IMPROVING OUTCOMES AND QUALITY OF LIFE	15
IMPACT OF INTERMITTENT LEVOSIMENDAN INFUSIONS ON HEART TRANSPLANTATION	15
REMOTE MONITORING OF HEART FAILURE PARAMETERS AFTER ATRIAL FIBRILLATION ABLATION WITH PULSED–FILED ENERGY: AN EXPLORATORY ANALYSIS	15
IDENTIFYING CARDIOGENIC SHOCK SUB–PHENOTYPES WITH MACHINE LEARNING: A MULTICENTER STUDY COMBINING CLINICAL AND ECHOCARDIOGRAPHIC DATA	15
EFFICACY OF PERCUTANEOUS STELLATE GANGLION BLOCK IN PATIENTS WITH ARRHYTHMIC STORM: WHICH ROLE DO ANAESTHETICS PLAY? DATA FROM A MULTICENTRE CASE STUDY	14
YOUNGER PATIENTS WITH LOW BLOOD HEMOGLOBIN LEVELS DURING ACUTE CORONARY SYNDROME HAVE HIGHER GLOBAL MORTALITY RISK THAN THE ELDERLY IN THE LONG–TERM FOLLOW UP	14
A CASE OF PROSTHETIC VALVE ENDOCARDITIS: WHEN PNEUMONIA IS NOT THE RIGHT ANSWER	14
RECURRENT DISSECTION OF LEFT CORONARY ARTERY WITH EXTENSION TO THE LEFT MAIN AND CARDIOGENIC SHOCK	14
POST–TRAUMATIC CORONARY DISSECTION: A RARE BUT POTENTIALLY LETHAL EVENT	13
WORKING GROUP FOR THE MANAGEMENT OF DYSLIPIDEMIA IN PATIENTS WITH ACUTE CORONARY SINDROMES: A TAILORED APPROACH	13
WEARABLE CARDIOVERTER DEFIBRILLATOR: ADHERENCE AND IMPACT ON PERCEIVED HEALTH STATUS IN A SINGLE CENTRE EXPERIENCE	13
ASSOCIATION BETWEEN REGULAR SPORT ACTIVITY AND RESTING HEART RATE VALUES IN A CROSS–SECTIONAL ADOLESCENT STUDY	13
489 A RARE CASE OF LEAD EXTRACTION	12
490 NT-PROBNP AND HIGH-SENSITIVITY TROPONIN T HOLD DIAGNOSTIC VALUE IN CARDIAC AMYLOIDOSIS	12
180 LONG TERM FOLLOW UP OF A NON-PROGRESSIVE LEFT MAIN CORONARY ARTERY FISTULA TO RIGHT ATRIUM	12
361 PATISIRAN EFFICACY ON MYOCARDIAL FUNCTION IN H-ATTR PATIENTS EVALUATED WITH THE USE OF CMR AND SPECKLE TRACKING ECOCARDIOGRAPHY	12
269 EFFECTS OF COLCHICINE TREATMENT AFTER MYOCARDIAL INFARCTION ON TOP OF STANDARD THERAPY: EVIDENCE FROM A PRECLINICAL STUDY	12
937 INCIDENTAL DIAGNOSIS OF ANOMALOUS ORIGIN AF A CORONARY ARTERY: BETTER LATE THAN NEVER.	12
672 TRANSCATHETER VS SURGICAL TREATMENT FOR PERCEVAL DEGENERATION: TAILORED STRATEGY FROM THE HEART TEAM	12
1082 LEFT VENTRICULAR FUNCTION ESTIMATION: WHEN VOLUMES MEASUREMENT IS NOT FEASIBLE	11
456 NATURAL HISTORY AND CLINICAL BURDEN OF MODERATE AORTIC STENOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS	11
366 RIGHT HEART FAILURE IN CARCINOID HEART DISEASE: A MULTIDISCIPLINARY APPROACH	11
373 ADONHERS (AGED DONOR HEART RESCUE BY STRESS ECHO) PROTOCOL FOR HEART DONATION FROM MARGINAL DONOR HEARTS: MONOCENTRIC RETROSPECTIVE STUDY ON RECIPIENT'S SURVIVAL AFTER 10-YEAR FOLLOW-UP	11
1129 IMAGING STRESS TEST OR CORONARY COMPUTED TOMOGRAPHY PRIOR TO NON-CARDIAC SURGERY? A SEVEN YEARS SINGLE CENTRE EXPERIENCE	11
1094 MULTIVESSEL CORONARY ARTERY SPASM TRIGGERED BY GANGLIONATED PLEXI STIMULATION DURING ATRIAL FIBRILLATION RADIOFREQUENCY CATHETER ABLATYION: A CASE REPORT	11
784 IMPACT OF ELECTIVE, UNCOMPLICATED TARGET LESION REVASCULARIZATION ON CARDIAC MORTALITY AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION OF UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE	11
835 CARDIOMYOPATHIES: IS IT USEFUL TO ANALYZE MINOR GENES?	11
270 PARTICULAR MISDIAGNOSED ACS-NSTEMI IN A YOUNG ADULT WITH HISTORY OF HODGKIN'S LYMPHOMA IN THE ERA OF FREQUENT SARS-COV2 RELATED MYOCARDITIS: NOTHING SHOULD EVER BE LEFT TO CHANCE.	11
88 INCIDENTAL DIAGNOSIS OF MASSIVE MOBILE LEFT VENTRICLE THROMBI FOLLOWING COVID-19 INFECTION IN A HEART FAILURE PATIENT	11
Seeking and treating inflammation in ischaemic heart disease: are we ready?	10
752 CARDIOGENIC SHOCK AS THE FIRST PRESENTATION OF ACUTE ANTRACYCLINE CARDIOTOXICITY: A CLINICAL CASE	10
346 IMPACT OF EXERCISE-INDUCED PULMONARY HYPERTENSION ON THE RIGHT VENTRICLE AND WORSENING OF CARDIOVASCULAR RISK IN HIV PATIENTS	10
633 THE EFFECTS OF AEROBIC EXERCISE TRAINING ON CARDIOPULMONARY EXERCISE TESTING AND HEART FAILURE BIOMARKERS IN ADULT PATIENTS WITH HYPOPLASTIC LEFT HEART SYNDROME AND FONTAN CIRCULATION	10
A new application of computed tomography: stereotactic radiotherapy in the treatment of ventricular arrhythmias	10
May Measurement Month 2021: an analysis of blood pressure screening campaign results from India	10
DIAGNOSTIC CRITERIA FOR NON–DILATED LEFT VENTRICULAR CARDIOMYOPATHY WITH PROGNOSTIC SIGNIFICANCE	9
C81 ROLE OF RESTRICTIVE DIASTOLIC DYSFUNCTION FOR RISK STRATIFICATION OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: A BAYESIAN MODEL AVERAGING	9
Assessment of Myocardial Viability by Speckle Tracking in Patients with Late Presentation Acute Myocardial Infarction	9
Challenges in diagnosing and treating iatrogenic pulmonary vein stenosis: a novel percutaneous approach	9
185 BETA-BLOCKERS OR CALCIUM CHANNEL BLOCKERS IN HYPERTROPHIC CARDIOMYOPATHY	9

Myocardial infarction and viral triggers: what do we know by now?	9
Unlocking the enigma: decoding premature ventricular complexes for effective clinical assessment and risk management	9
731 MULTICENTRE OBSERVATIONAL REGISTRY OF PATIENTS HOSPITALIZED FOR HEART FAILURE AND REAL-LIFE ADHERENCE TO INTERNATIONAL GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH ACUTE AND CHRONIC HEART FAILUR	9
P321 NEOVASC REDUCER IMPLANTATION AS A USEFUL THERAPEUTIC CHANCE IN REFRACTORY ANGINA	8
Is it possible that angioplasty does not improve the quality of life in patients with stable angina?	8
The comeback of digitalis (digitoxin): the DIGIT-HF trial	8
Assessment of cardiac functions using two-dimensional transthoracic and speckle tracking echocardiography after treatment with SGLT2 inhibitors in Patients with HFrEF	8
P178 OCCASIONAL ECHOCARDIOGRAPHIC DIAGNOSIS OF BRONCHOGENIC CYST	8
P117 TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH CHRONIC THROMBOCYTOPENIA: PREVALENCE AND IN–HOSPITAL OUTCOMES	8
Treatment of acute pulmonary embolism: anticoagulation, fibrinolysis, and thrombectomy compared	8
P130 FINGER ISCHEMIA IN A YOUNG LADY: EXPECT THE UNEXPECTED FROM A PAPILLARY FIBRO–ELASTOMA	8
C77 GENDER GAP IN TIME TO ST–ELEVATION MYOCARDIAL INFARCTION DIAGNOSIS: A RETROSPECTIVE COHORT STUDY	8
P312 TAKOTSUBO SYNDROME DURING INFECTIVE ENDOCARDITIS: AN UNUSUAL COMBINATION	8
Focus on lipoprotein(a)	8
P234 IT IS TIME THAT ITALIAN AMI NETWORKS ARE BASED ON DIAGNOSTIC–THERAPEUTIC PATHWAYS INCLUDING BOTH TYPES OF ACS (STEMI AND NSTEMI)	8
P464 ELEVATED SPONTANEOUS INR: THE COMPLEXITY OF REAL LIFE BETWEEN CARDIOLOGY AND HEMATOLOGY	8
P245 IMPLICATIONS IN PHARMACOLOGICAL AND ELECTRICAL OPTIMIZATION IN HEART FAILURE: A EMBLEMATIC CASE	8
P224 THE SHARK–FIN THAT EMERGES AND IMMERGES: A CASE REPORT OF TRANSIENT AND REPETITIVE TRIANGULAR QRS–ST–T	7
P46 TRANSAXILLARY MITRAL VALVE SURGERY IS ASSOCIATED WITH EARLY RECOVERY AND SHORTER ICU AND HOSPITAL STAY	7
CASE REPORT: SELF–EXPANDING TRANSCATHETER VALVE IMPLANTATION (ACURATE NEO 2) IN A VERY SMALL NATIVE AORTIC ANNULUS	7
P255 A GOOD PERSPECTIVE NEEDS TWO POINT OF VIEW: TRANSVENOUS CRT–D LEAD EXTRACTION COMPLICATED BY INTRAOSSEUS COURSE OF THE CORONARY SINUS LEAD	7
P238 THE HEART LOGIC EXPERIENCE IN OUR CENTER “SANTA MARIA DELLA MISERICORDIA” HOSPITAL, UDINE	7
SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITOR DAPAGLIFLOZIN REDUCES SYSTEMIC H–FABP AND MONOCYTE–TO–LYMPHOCYTE RATIO IN PRECLINICAL MODELS OF ANTRACYCLINE INDUCED CARDIOTOXICITY	7
P413 A CASE OF PERIPARTUM DILATED CARDIOMYOPATHY WITH SEVERE BIVENTRICULAR DYSFUNCTION	7
SEVERE SYMPTOMATIC MITRAL REGURGITATION AFTER ANNULOPLASTY FAILURE: SUCCESSFUL TRANSCATHETER EDGE TO EDGE REPAIR	7
LONG–TERM FUNCTIONAL LIMITATIONS ON CARDIOPULMONARY EXERCISE TESTING IN A COHORT OF PATIENTS WITH EMOTIONS–TRIGGERED TAKOTSUBO SYNDROME	7
PROGNOSTIC VALUE MEAN PULMONARY ARTERIAL PRESSURE AND PULMONARY VASCULAR RESISTANCE IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AT FOLLOW–UP	6
OUTCOME OF OUT OF HOSPITAL CARDIAC ARREST: ARE THERE GENDER DIFFERENCES?	6
A CASE OF DUAL–SITE LEFT VENTRICULAR PACING PERFORMED VIA A PERSISTENT LEFT SUPERIOR VENA CAVA IN A PATIENT WITH COMPLETE ATRIO–VENTRICULAR BLOCK AND RIGHT SUPERIOR VENA CAVA OCCLUSION	6
THE OUTPATIENT CLINIC FOR PATIENTS WITH HEART FAILURE: A PROPOSAL FOR ADVANCED NURSING	6
ROLE OF THE NURSE IN MANAGING INVASIVE BLOOD PRESSURE MONITORING	6
ADVANCED CARDIAC IMAGING IN LIVER TRANSPLANTATION ECHOCARDIOGRAPHIC VENTRICULAR STRAIN AS PROGNOSTIC TOOLS	6
PREDICTING ADVERSE OUTCOMES IN HYPERTROPHIC CARDIOMYOPATHY:THE PIVOTAL ROLE OF CARDIOPULMONARY EXERCISE TESTING	6
HALF DOSE THROMBOLYSIS IN INTERMEDIATE – HIGH RISK PULMONARY EMBOLISM WITH TRICUSPID VALVE MOBILE MASS: A BAIL OUT STRATEGY	6
RESIDUAL CARDIOVASCULAR RISK AND SEVERITY OF CORONARY DISEASE	6
THE EFFICACY OF VERY LOW CALORIE KETOGENIC DIET (VLCKD) ON CARDIO–METABOLIC PROFILE IN PATIENTS WITH OBESITY	6
TELECUORE: FEASIBILITY OF A HOSPITAL–TERRITORIAL TELEMEDICINE PROJECT IN CHRONIC HEART FAILURE	6
HYPERTENSIVE EMERGENCIES AND URGENCIES: ADHERENCE TO GUIDELINES AND RELATIONSHIP BETWEEN BLOOD PRESSURE MANAGEMENT AND IN–HOSPITAL MORTALITY	6
TRANSTYRETIN CARDIAC AMYLOIDOSIS IN ELDERLY PATIENTS: ALWAYS A WILD TYPE?	6
ACUTE MYOCARDIAL INJURY IN A PATIENT WITH TYPE–1 NEUROFIBROMATOSIS: A CASE OF SUSPECTED PHEOCROMOCYTOMA–ASSOCIATED MYOCARDITIS	6
DON’T FORGET ABOUT CARDIAC AMYLOIDOSIS: WHEN RED FLAGS MATTER	6
YOUNG WOMAN WITH LEFT VENTRICULAR DYSFUNCTION AND MITRAL LAMBL EXCRESCENCE: WHAT TO DO WHEN ISCHEMIC STROKE IS RECURRENT?	6
GUIDEWIRE SHAPE MODIFICATION: A SIMPLE TECHNIQUE TO PREVENT CONDUCTION SYSTEM INJURIES DURING TRANSCATHETER VALVE IMPLANTATION	6
EXPLORING THE 12 LEAD ECG CHARACTERISTIC OF PAEDIATRIC AND YOUNG ADULT CARRIERS OF DESMOPLAKIN GENE VARIANTS	6
LIPID–LOWERING THERAPY WITH PCSK9 INHIBITORS: FAMILIAL HYPERCHOLESTEROLEMIA VS GENERAL POPULATION OUTCOMES	6
THE HEART‘S ABILITY TO "SELF–DEFIBRILLATE": A SPECIAL CASE OF IDIOPATHIC VENTRICULAR TACHYCARDIA	6
REAL–WORLD SOTATERCEPT ELEGIBILITY: ANALYSIS FROM FOCUS–PAH REGISTRY	6
676 A PITFALL IN ECHOGRAPHIC DIAGNOSIS OF ABDOMINAL AORTIC ANEURYSM: WHEN PARA-AORTIC LYMPH NODES REQUIRE ATTENTION	5
43 CARDIAC TROPONINS AND COVID-19: WHAT DO WE KNOW ABOUT HETEROPHILIC ANTIBODIES?	5
829 IMPACT OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS ON CARDIAC REMODELLING IN LOW RISK PATIENTS WITH TYPE 2 DIABETES MELLITUS	5
534 PROGNOSTIC IMPACT OF CONTRAST-INDUCED ACUTE KIDNEY INJURY IN OLDEST OLD STEMI PATIENTS: A MULTICENTER REGISTRY	5
Scenarios in precision medicine: proteomics in heart failure	5
421 CARDIO-NEURO ABLATION WORKFLOW OPTIMIZATION USING THE CARTO 3 SYSTEM CFAE MODULE	5
1153 SODIUM GLUCOSE COTRANSPORTER-2 INHIBITORS ELIGIBILITY IN PATIENTS WITH HEART FAILURE ACROSS THE SPECTRUM OF EJECTION FRACTION	5
890 ARTIFICIAL INTELLIGENCE EMPOWERS REMOTE MONITORING OF IMPLANTABLE LOOP RECORDERS	5
665 THE UNFORSEEN MECHANISM: A CASE OF DISTRIBUTIVE SHOCK SECONDARY TO REACTIVE HAEMOPHAGOCYTIC SYNDROME LEADING TO SEVERE REVERSIBLE BIVENTRICULAR DYSFUNCTION.	5
162 HFREF WITH IMPROVED EJECTION FRACTION AFTER CORONARY ARTERY BYPASS GRAFT (CABG) AND REVERSE REMODELING PREDICTOR FACTORS	5
682 UNEXPECTED TRIGLYCERIDES-LOWERING EFFECT OF A NOVEL NUTRACEUTICAL COMPOUND FOR IBS	5
722 NATURAL ACTIVATORS OF AUTOPHAGY PROTECT THE HEART FROM DOX-INDUCED CARDIOMYOPATHY	5
30 EVOLOCUMAB USE IN CLINICAL PRACTICE IN ITALY: FINAL DATA OF THE HEYMANS STUDY.	5
1106 CLINICAL AND MULTIMODAL IMAGING FOLLOW-UP OF PATIENTS WITH MYOPERICARDITIS FOLLOWING MRNA COVID-19 VACCINATION	5
1026 MYOCARDIAL INFARCTION AND STROKE IN A YOUNG PATIENT AFFECTED BY LES: KEY ROLE OF AN INTEGRATED IMAGING APPROACH	5
111 POST-OPERATIVE OUTCOME OF ADULT PATIENTS WITH PRE-TRICUSPID SHUNT UNDERGOING DEFECT CLOSURE	5
587 LEFT ATRIAL APPENDAGE OCCLUSION: A REAL SOLUTION TO CARDIOEMBOLIC RISK OF ATRIAL FIBRILLATION?	5
FRACTIONATED PROCEDURAL RISK OF MORTALITY IN A VERY FRAIL PATIENT: CASE REPORT OF A TAILORED HYBRID APPROACH	4
85 ATRIAL FIBRILLATION INCIDENCE IN SARS-COV-2 INFECTED PATIENTS: PREDICTORS AND RELATIONSHIP WITH IN-HOSPITAL MORTALITY	4
647 COMPLEX PERCUTANEOUS CORONARY INTERVENTION IN HIGHT BLEEDING AND THROMBOTIC RISK PATIENT: WHICH ANTITHROMBOTIC THERAPY?	4
395 ASSESSMENT OF VENTRICULAR ARRHYTHMIAS IN PATIENTS UNDERGOING TRANCATHETER AORTIC VALVE IMPLANTATION (TAVI): IMPACT ON CLINICAL OUTCOME	4
CONTEMPORARY OUTCOMES OF DEGENERATIVE MITRAL VALVE SURGERY IN A REGIONAL TERTIARY CARE CENTER	4
Disparities between cardiologists and oncologists therapeutic strategies in cardio-oncology. A national cross-sectional survey	4
Cardiovascular follow-up outpatient clinic and cardiovascular follow-up notebook for cancer survivor	4
BASAL AND POST–STRESS CERT1 RISK SCORE PREDICTS ALL–CAUSE MORTALITY AND NONFATAL MYOCARDIAL INFARCTION IN PATIENTS WITH ESTABLISHED OR SUSPECTED CORONARY ARTERY DISEASE UNDERGOING STRESS MYOCARDIAL PE	4
THE ADDING VALUE OF NON–INVASIVE ASSESSMENT OF STROKE VOLUME DURING CARDIOPULMONARY EXERCISE TESTING IN HYPERTROPHIC CARDIOMYOPATHY: BEYOND O2–PULSE	4
1066 THE USEFULNESS OF CEREBRAL PROTECTION DURING TAVR: A METANALYSIS	4
54 EXPLORING FEATURES AND OUTLOOK OF WOMEN DISCHARGED AFTER AN ACUTE CORONARY SYNDROME MANAGED INVASIVELY: INSIGHTS FROM THE 23,072 PATIENTS PRAISE MULTICENTER REGISTRY	4
Critical analysis of the 2023 ESC guidelines on cardiomyopathy management	4
When Brugada syndrome is at risk of sudden death: clinical and anatomical aspects	4
EFFICACY AND SAFETY OF INCLISIRAN IN OUTPATIENTS WITH RECENT ACUTE CORONARY SYNDROME	4
CLINICAL ADVANTAGE OF THE USE OF ADVANCED ALGORITHMS FOR THE MANAGEMENT OF HEART FAILURE IN PATIENTS UNDERGOING IMPLANTATION OF CARDIAC CONTRACTILITY MODULATION DEVICES	4
May Measurement Month 2022: an analysis of blood pressure screening results from Kazakhstan	4

Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy	4
INTERDEPARTMENTAL CLINICAL PATHWAY FOR THE MANAGEMENT OF HYPERCHOLESTEROLEMIA IN PRIMARY AND SECONDARY PREVENTION	4
216 ARRHYTHMOGENIC CARDIOMYOPATHY: IS THERE EVIDENCE OF AN INFLAMMATORY MYOCARDIAL DISEASE?	4
CARDIAC MAGNETIC RESONANCE IN A CASE OF RECURRENT MESALAZINE–INDUCED MYOCARDITIS	4
MYOCARDITIS CAUSED BY GRANULOCYTE COLONY STIMULATING FACTOR ADMINISTRATION IN A HEALTHY HEMATOPOIETIC STEM CELLS DONOR: A CASE REPORT	4
3D strain echocardiography in detection of subclinical left ventricle dysfunction as a marker of early-onset anthracycline cardiotoxicity among children treated for acute lymphoblastic leukemia	4
SURGICAL MANAGEMENT OF QUADRICUSPID AORTIC VALVE	4
ELECTROANATOMIC ACTIVATION MAPPING OF KOCH TRIANGLE IN AVNRT PATIENTS	4
Biomimetic CD31-coated stent maintains physiological performance under high barotrauma in pigs	3
654 ECHOCARDIOGRAPHIC PARAMETERS AND CLINICAL OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION AND CORONARY MICROVASCULAR DYSFUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS	3
164 HIGH HDL CHOLESTEROL INCREASES CARDIOVASCULAR RISK IN HYPERTENSIVE PATIENTS	3
Reduction of cerebrovascular and peripheral events with PCSK9 inhibitors: Does it just depend on the lowering of the low-density lipoprotein?	3
Tailoring antiplatelet therapy duration after PFO closure: insights from the PROLONG registry	3
Validation and comparison of prognostic scores for severe tricuspid regurgitation	3
Digitally enabled cardiac rehabilitation following coronary revascularization: results from a single centre feasibility study	3
Pollution and coronary risk: how much does it matter?	3
Baseline physiologic characteristics of participants in the APOLLO ( Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation) study assessed by MRI: preliminary results	3
139 INTRAVENOUS CONTINUOUS HOME INOTROPIC THERAPY IN ADVANCED HEART FAILURE - RESULTS AND PRACTICAL GUIDELINES	3
326 STAGED ENDOVASCULAR TREATMENT FOR MULTIVALVULAR HEART DISEASE: A CASE REPORT	3
Outcomes of transradial versus transfemoral secondary access in transcatheter aortic valve implantation: a systematic review and meta-analysis	3
354 THE ADDED VALUE OF MYOCARDIAL WORK IN EARLY DETECTION OF SYSTOLIC DYSFUNCTION IN CARDIAC AMYLOIDOSIS	3
Mycophenolate mofetil as second-line therapy for steroid-refractory ICI-induced myocarditis	3
113 RIGHT VENTRICULAR FREE WALL LONGITUDINAL STRAIN AS THE SOLE MARKER OF RIGHT VENTRICLE SYSTOLIC DYSFUNCION IN HYPERTROPHIC CARDIOMYOPATHY: A CLINICAL CASE	3
588 EXPLORING THE IMPACT OF SEVERE SECONDARY TRICUSPID REGURGITATION ON REST AND EXERCISE HEMODYNAMICS OF PATIENTS WITH HEART FAILURE AND A PRESERVED LEFT VENTRICULAR EJECTION FRACTION	3
Accessory Fascicolo-Ventricular Pathway in Hypertrophic Phenotype Cardiomyopathy Suspected for Prkag2 Mutation: Diagnostic Role of Myocardial Biopsy	3
Impact of guideline-directed medical therapy on outcomes of mitral transcatheter edge-to-edge repair	3
Scarring/arrhythmogenic cardiomyopathy	3
The impact of COVID-19 and COVID vaccination on cardiovascular outcomes	3
Percutaneous coronary intervention for left main coronary artery disease: temporal trends and in-hospital outcomes from a 12-year consecutive cohort	3
253 EXCERCISE-INDUCED PULMONARY HYPERTENSION AND CORONARY ARTERY ANOMALY: AN UNUSUAL ASSOCIATION	3
May Measurement Month 2021: an analysis of blood pressure screening results from the Philippines	3
How an innovative catheter with temperature control and very high-power, short-duration ablation changed our approach to the treatment of persistent atrial fibrillation	3
Cell painting based high-content phenotypic screening to elucidate kinase signaling pathways in ibrutinib-mediated atrial fibrillation	3
Transcatheter edge-to-edge repair for mitral regurgitation across age groups: a propensity-matched cohort study	3
991 A PATIENT WITH INFERIOR Q WAVES AND CHEST PAIN: WHEN HOOF BEATS ARE NOT HORSES	3
Procedural safety and mid-term outcomes after valve-in-valve transcatheter aortic valve implantation: a prospective single-center study	3
1120 DIAGNOSTIC ACCURACY OF SMART GADGETS/WEREABLE DEVICES IN ATRIAL FIBRILLATION DETECTION: A METANALYSIS	3
Impact of a multimodal prehabilitation program on the cardiovascular risk profile of high-risk oncologic and non-oncologic patients undergoing major colorectal surgery	3
532 SEX-RELATED DIFFERENCES IN THROMBUS BURDEN IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION	3
201 CTLA-4 AND PD-1 BLOCKING AGENTS INCREASES SYSTEMIC SDF-1, CARDIAC DAMPS FIBRONECTIN EDA, S-100 CALGRANULIN, GALECTINE-3 AND NLRP-3/MYD-88 CHEMOKINE PATHWAYS	3
Clinical Efficacy Observation of Lacrimal Intubation Surgery for the Treatment of Lacrimal Passage Stenosis or Obstruction	3
The advantages of physiological pacing	3
State-of-the-art practice in 3VD CAD combining predictive score, contemporary CTO expertise, angiography-derived physiology, intravascular Imaging and P2Y12 mono therapy: The Multivessel TALENT	3
1054 GENDER DIFFERENCES IN MINOCA POPULATION	3
Cardio-oncology blitz registry offers real-world data in a gastrointestinal cancer population	3
When anticoagulant therapy is not enough: recurrent stroke	3
Cardiomyocyte-derived exosomes: linking heart failure to tumour progression	3
Territorial longitudinal strain and regional RCA myocardial work in patients with chronic coronary syndrome and presence of right coronary artery total chronic occlusion	3
Factor XI inhibition in patients with acute coronary syndrome	3
745 INTERDISCIPLINARY EVALUATION IN RESISTANT ARTERIAL HYPERTENSION	3
Does the short-term cardioprotection prevent diastolic dysfunction?	3
661 TWO CARDIOMYOPATHIES IN ONE HEART: LESSONS FROM CLINICAL CASE	3
Bruton tyrosine kinase inhibitors at the time of cardio-oncology: proving safety on right ventricular function and afterload	3
Pattern of cardiovascular admission diagnoses during the month of Ramadan: a single center experience	3
P230 A RARE CASE OF INFECTIVE MYOCARDIAL INFARCTION	2
P390 CARDIAC INVOLVEMENT IN A VERY RARE CASE OF CUTIS LAXA	2
P205 COMPASSIONATE DRUG USE FOR PATIENTS WITH TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: THE FIRST EXPERIENCE IN ITALY	2
P366 FULMINANT MYOCARDITIS WITH SPONTANEOUS RESOLUTION AFTER COVID 19 AND ALLERGIC EPISODE: MIS–A OR ALLERGIC MYOCARDITIS?	2
The diagnostic value of electrocardiogram in the left variants of desmosomal arrhythmogenic cardiomyopathy	2
Cerebral haemorrhage in the patient with atrial fibrillation: do we employ the direct oral anticoagulants without waiting too long?	2
SPONTANEOUS CORONARY ARTERY DISSECTION (SCAD) WITH CARDIAC ARREST AT PRESENTATION: A SUBANALYSIS FROM THE DISCO REGISTRY	2
Screening for dilated cardiomyopathy in immediate family members: to whom, how, when (and where)	2
A NEW PROJECT OF A SPECIFIC EXERCISE PROTOCOL FOR AMBULATORY CARDIOVASCULAR REHABILITATION SPECIFIC FOR HEART FAILURE: REPORT OF THE FIRST EXPERIENCE	2
REPEATED ABLATION PROCEDURE IN A PERSISTENT ATRIAL FIBRILLATION POPULATION. THE ROLE OF VEIN OF MARSHALL ETHANOL INFUSION COMBINED WITH AN ANATOMICAL ABLATION SETUP	2
New strategies for valve replacement and interventional options in adults with congenital heart disease: new insights from Euro-ACHD 2025	2
The prognostic significance of microvascular resistance reserve: a systematic review and meta-analysis	2
PLATYPNEA–ORTHODEOXIA SYNDROME SECONDARY TO TRAUMATIC TRICUSPID VALVE RUPTURE: A CASE REPORT	2
ANMCO position paper ‘Hypertrophic cardiomyopathy: from diagnosis to treatment’	2
P353 A CASE OF FABRY DISEASE WITH ISOLATED CARDIAC INVOLVEMENT	2
P287 RELATIONSHIP OF HYPOVITAMINOSIS D WITH HEART FAILURE DEVELOPMENT, HEART TRANSPLANTATION NECESSITY AND MORTALITY AMONG INDIVIDUALS WITH DILATED CARDIOMYOPATHY	2
P192 POSTINFARCTION VENTRICULAR SEPTAL DEFECT: MANAGEMENT AND A NEW SURGICAL OPTION FOR CLOSURE	2
TOTAL ENDOSCOPIC MITRAL VALVE REPAIR IN A MARFAN GIRL WITH BARLOW DISEASE AND CHEST DEFORMITY WITH A VIRTUAL AND AUGMENTED REALITY TECHNOLOGY SUPPORT	2
P257 UNIQUE UNEXPECTED COURSE OF A S–ICD LEAD: DIAGNOSTIC CHALLENGES AND SAFE CLINICAL AND INTERVENTIONAL MANAGEMENT	2
THE APEX TALKS…CARDIAC METASTASIS MIMICKING ST SEGMENT ELEVATION MYOCARDIAL INFARCTION	2
CLINICAL AND GENETIC FEATURES OF JUVENILE ONSET LONE ATRIAL FIBRILLATION	2
CARDIAC REMODELING AND OUTCOME AFTER SURGICAL INTERVENTION FOR ATRIAL FUNCTIONAL MITRAL REGURGITATION	2
ST SEGMENT DEPRESSION: MUCH ADO ABOUT NOTHING	2
CARDIAC MEMORY PRESENTING AS ST ELEVATIONS FOLLOWING REENTRANT SUPRAVENTRICULAR TACHYCARDIAS	2
593 PRESENTATION AND OUTCOME OF PATIENTS WITH COEXISTING CARDIAC AL AND ATTR AMYLOIDOSIS	2
Sex differences in characteristics and outcomes after TAVR-in-TAVR: the PANDORA international registry	2
The new in anticoagulation: factor XI inhibitors	2
An aggressive solution for patients with heart failure and atrial fibrillation: nodal ablation and cardiac resynchronization therapy	2
A novel sirolimus-coated balloon versus a paclitaxel-coated balloon for coronary artery disease: the SELSEQ registry	2
P484 IMPACT OF VISCERAL FAT ON MORTALITY IN PATIENTS TREATED BY TAVI	2
P142 EARLY MANAGEMENT OF STEMI PATIENTS DURING COVID–19 PANDEMIC: THE ROLE OF AN EMERGENCY DEPARTMENT–BASED CARDIOLOGY UNIT IN SAN RAFFAELE SCIENTIFIC INSTITUTE	2
P271 CASEOUS CALCIFICATION OF THE MITRAL ANNULUS: ROLE OF 3D ECHOCARDIOGRAPHY	2
Present and future of endomyocardial biopsy in cardiac amyloidosis	2
GENDER DIFFERENCES IN PREDICTORS OF PRIMARY VENTRICULAR FIBRILLATION: RESULTS OF THE PREDESTINATION STUDY	2
THE “BACK TO THE FUTURE” OF CARDIOTHORACIC SURGERY: HIGH–RISK INTERVENTIONAL PROCEDURE TURNED DOWN TO CONVENTIONAL CARDIAC SURGERY	2
NOT JUST A SIMPLE FEVER: DIAGNOSIS OF COMPLICATED INFECTIVE ENDOCARDITIS ON BICUSPID AORTIC VALVE IN A YOUNG MAN	2
P364 LOW–DENSITY LIPOPROTEIN CHOLESTEROL REDUCTION IN PATIENTS AT VERY HIGH CARDIOVASCULAR RISK	2
Treating chronic kidney disease to reduce cardiovascular risk	2
EFFICACY AND SAFETY OF PULSED–FIELD ABLATION VERSUS THERMAL ABLATION FOR ATRIAL FIBRILLATION IN REAL–WORLD CLINICAL PRACTICE: A META–ANALYSIS	2
May Measurement Month 2021: an analysis of blood pressure screening results from Nepal	2
Correlation analysis of Gensini score in T2DM patients with STEMI	2